Pembrolizumab for Hodgkin's Lymphoma User Reviews
Brand names: Keytruda
- Jos...
- Taken for 1 to 6 months
- March 22, 2025
Pembrolizumab "No problems after 6 infusions. Previous prostate cancer led to removal of prostate. Check-up discovered non-Hodgkin's lymphoma. Melanoma discovered during lymphoma check-up. Have my fingers crossed on this one."
- joh...
- Taken for 1 to 2 years
- January 26, 2025
"Ending usage in a few months - apparently no use after that. For recurrent CHL and been on it for almost a couple of years, in an older gentleman. So far, so good, but no imaging since started. No lumps or bumps or any sign of recurrence. Side effects known include mild cramping and some itching sites."
Frequently asked questions
- Pembrolizumab vs. nivolumab: How do they compare?
- What type of cancer is pembrolizumab used for?
- How are Inlyta and Keytruda used in kidney cancer?
- How does pembrolizumab affect the immune system?
See also:
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
Learn more about Hodgkin's Lymphoma
Care guides
Symptoms and treatments
More about pembrolizumab
- Check interactions
- Compare alternatives
- Reviews (290)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Pembrolizumab "Recurrent Hodgkin lymphoma and Keytruda put me in remission immediately, first infusion. It is a miracle drug for many! However, side effects after 7 months of treatment were becoming unbearable and ceased. Skin and lung issues from first month. Been 3 months since stopping infusions and seem to be improving!"